BCA
FLXN

Berman Capital Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Berman Capital Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
+615
New +$3.83K ﹤0.01% 1646

Other funds holding FLXN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berman Capital Advisors's FLXN Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Flexion Therapeutics, Inc. (FLXN) in Q3 2021: 615 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1646 among its holdings.

145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • Berman Capital Advisors held 615 shares of Flexion Therapeutics, Inc. worth $3K as of Q3 2021.
  • Flexion Therapeutics, Inc. was a new Berman Capital Advisors position in Q3 2021.
  • Flexion Therapeutics, Inc. made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1646 holding.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.